Wedmont Private Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Buy
26,148
+6,550
+33% +$356K 0.03% 310
2026
Q1
$1.23M Sell
19,598
-2,619
-12% -$210K 0.04% 263
2025
Q4
$2.19M Buy
22,217
+252
+1% +$24.7K 0.08% 149
2025
Q3
$2.11M Sell
21,965
-215
-1% -$22.3K 0.08% 153
2025
Q2
$2.28M Buy
22,180
+625
+3% +$63.2K 0.1% 129
2025
Q1
$2.02M Buy
21,555
+1,319
+7% +$133K 0.1% 117
2024
Q4
$1.92M Buy
20,236
+1,506
+8% +$133K 0.1% 116
2024
Q3
$1.58M Buy
18,730
+1,574
+9% +$124K 0.09% 135
2024
Q2
$1.33M Buy
17,156
+2,242
+15% +$164K 0.08% 148
2024
Q1
$1.02M Buy
14,914
+619
+4% +$39.8K 0.07% 176
2023
Q4
$835K Buy
14,295
+1,684
+13% +$89.9K 0.07% 196
2023
Q3
$661K Buy
12,611
+384
+3% +$20.1K 0.07% 205
2023
Q2
$648K Buy
12,227
+1,202
+11% +$62.8K 0.07% 192
2023
Q1
$555K Buy
11,025
+1,127
+11% +$53.1K 0.07% 199
2022
Q4
$459K Buy
9,898
+1,250
+14% +$54.1K 0.07% 220
2022
Q3
$335K Buy
+8,648
New +$347K 0.07% 226
2022
Q2
Sell
-6,677
Closed -$295K 342
2022
Q1
$295K Buy
+6,677
New +$289K 0.07% 238

Other funds holding BSX

Wedmont Private Capital's BSX Position: Q2 2026 in Review

Wedmont Private Capital increased its Boston Scientific (BSX) stake by 33% in Q2 2026, buying an estimated $356K and bringing the position to 26,148 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #310.

Wedmont Private Capital first reported a position in BSX in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.28M in Q2 2025. 164 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Wedmont Private Capital held 26,148 shares of Boston Scientific worth $1.17M as of Q2 2026.
  • Wedmont Private Capital bought 6,550 Boston Scientific shares in Q2 2026, an estimated $356K.
  • Boston Scientific made up 0.03% of Wedmont Private Capital's portfolio in Q2 2026, its #310 holding.
  • Wedmont Private Capital first reported a position in Boston Scientific in Q1 2022 and has held it in 17 quarters since.
  • Wedmont Private Capital's Boston Scientific position peaked at $2.28M in Q2 2025.
  • 164 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Wedmont Private Capital's 13F filing for Q2 2026, filed 13 Jul 2026.